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[ABSTRACT] The present study was undertaken to evaluate the influence of the methanolic fruit extract of Momordica cymbalaria 
(MFMC) on PPARγ (Peroxisome Proliferator Activated Receptor gamma) and GLUT-4 (Glucose transporter-4) with respect to glucose 
transport. Various concentrations of MFMC ranging from 62.5 to 500 μg·mL−1 were evaluated for glucose uptake activity in vitro us-
ing L6 myotubes, rosiglitazone was used as a reference standard. The MFMC showed significant and dose-dependent increase in glu-
cose uptake at the tested concentrations, further, the glucose uptake activity of MFMC (500 μg·mL−1) was comparable with rosigilita-
zone. Furthermore, MFMC has shown up-regulation of GLUT-4 and PPARγ gene expressions in L6 myotubes. In addition, the MFMC 
when incubated along with cycloheximide (CHX), which is a protein synthesis inhibitor, has shown complete blockade of glucose 
uptake. This indicates that new protein synthesis is required for increased GLUT-4 translocation. In conclusion, these findings suggest 
that MFMC is enhancing the glucose uptake significantly and dose dependently through the enhanced expression of PPARγ and 
GLUT-4 in vitro. 
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Introduction 
Medicinal plants with their natural phytoconstituents 
form a base for the discovery of new chemical entities in 
modern drug discovery. A significant number of plant-derived 
active principles having therapeutic use in the treatment of 
type 2 diabetes mellitus have been reported [1]. In this context, 
the various plant parts of Momordica cymbalaria Fenzl ex 
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Naudin (Cucurbitaceae) have been demonstrated to have 
antidiabetic and hypoglycemic activity [2-4]. However, the rate 
limiting step in glucose utilization is glucose transport, espe-
cially in insulin-targeted skeletal muscle, mediated by major 
glucose transporters (GLUT proteins, GLUT-4 and GLUT-1) 
[5]. Cloning and characterization of insulin responsive glucose 
transporters has revealed that GLUT-1 and GLUT-4 are ex-
pressed in human skeletal muscle [6]. Insulin resistance in type 
2 diabetes is characterized by decreased insulin-stimulated 
glucose transport and weakened metabolism in adipocytes 
and skeletal muscle resulting in down-regulation of the major 
insulin responsive GLUT’s [7]. 
Weakened GLUT-4 translocation, and reduced expression 
of peroxisome proliferator activated receptor gamma (PPARγ) 
have been studied under diabetic conditions.  Studies have 
shown the role of PPARγ in insulin signaling, and also enumer-
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ated the up-regulation of insulin-dependent glucose transport 
and GLUT-4 translocation in cultured L6 myotubes [8]. 
PPARγ, a transcription factor belonging to the nuclear 
receptor superfamily [9], is essential for adipocyte differentia-
tion [10], and PPARγ agonists directly enhances insulin signal-
ling and glucose uptake in the muscles by binding with the 
PPARγ receptors [8]. 
Previously, various plant parts of M. cymbalaria, were 
extensively studied for their hypoglycemic and antidiabetic 
activity. However, no studies related to its mechanism of ac-
tion have been carried out, and hence the molecular aspects of 
the mechanism behind the hypoglycemic and antidiabetic 
effects of M. cymbalaria need to be explored. With this back-
ground, the present study was carried out to exemplify the 
molecular mechanistic action of MFMC, at the cellular level, 
by evaluating the influence of MFMC on glucose transport 
(GLUT-4), and PPARγ expression using L6 myotubes in vitro. 
Materials and Methods 
Reagents, chemicals, and cell lines 
All cell culture supplements were purchased from Sig-
ma-Aldrich (St. Louis, MO, USA). All fine chemicals, TRI 
reagent, and Avian Moloney Leukemic virus reverse tran-
scriptase (AMLV), dNTP, and Taq polymerase were also pur-
chased from Sigma-Aldrich. All other reagents and chemicals 
purchased were of molecular biology grade and were pur-
chased from Sigma-Aldrich. 
Collection of plant material 
The fruits of Momordica cymbalaria, were collected 
from Hospete (Bellary District, Karnataka, India), in the pe-
riod of May–June 2012, considered the seasonal conditions 
for obtaining maximum phytoconstituents. The collected plant 
material was authentified and certified by Prof. K. P. Srinath, 
Department of Botany, Bangalore University, Bangalore, a 
voucher specimen of the plant material is preserved in the 
department with specimen no. 2012-13/MC/BT-01.  
Plant material preparation 
The fruits of Momordica cymbalaria, were shade-dried 
and powdered. The fruit powder (50 g) was extracted sequen-
tially with hexane, dichloromethane, ethyl acetate, and me-
thanol, in a Soxhlet apparatus. Initially, the plant material was 
extracted with  hexane (1 L) at 60 °C for 24 h, the marc 
obtained was completely dried, and extracted with dichloro-
methane (1 L) for 24 h, and then the marc was extracted with 
ethyl acetate (1 L), followed by methanol (1 L).  
Extracts were concentrated in a rotor evaporator (Remi 
Instruments), under reduced pressure at room temperature, 
and dried extract (1 mg) was reconstituted to 1 mL with re-
spective solvents, and diluted to attain a final concentration of 
500 μg·mL−1, from the stock solution of 500 μg·mL−1 further 
concentrations were prepared by serial dilution (250, 125, 
62.5 μg·mL−1), for glucose uptake studies. 
Propagation and maintenance of L6 cells  
L6 cell cultures (rat skeletal muscle), was procured from 
the National Centre for Cell Sciences (NCCS), Pune, India.  
L6 cells were cultured and maintained in Dulbecco’s modified 
Eagle’s medium (DMEM), with 10% inactivated Fetal Bovine 
serum (FBS), along with penicillin (100 IU·mL−1), strepto-
mycin (100 μg·mL−1), and amphotericin B (5 μg·mL−1), in a 
humidified atmosphere of 5% CO2 at 37 °C, until confluence.  
The cells were dissociated with TPVG solution (0.2% trypsin, 
0.02% EDTA, and 0.05% glucose in PBS). The stock cultures 
were grown in 25 cm2 culture flasks.  
Glucose uptake assay 
Completely differentiated myotubes demonstrates a high 
response to insulin, and rosiglitazone mediated glucose up-
take. The differentiated myotubes were serum-starved over-
night, and washed with HEPES in Kreb’s Ringer phosphate 
solution (KRP buffer), and incubated with KRP buffer with 
0.1% BSA (Bovine serum albumin) for 30 min at 37 °C. The 
myotubes were treated with various concentrations of plant 
extract, and standard along with vehicle control, in 60 mm 
Petri plates. Subsequently, D-glucose solution was added to 
all the plates, and incubated for 30 min at 37 °C. Subse-
quently, the liquid medium was aspirated from all the plates, 
to terminate the glucose uptake, and the cells were washed 
three times with ice-cold KRP buffer solution. Further, the 
cells were lysed with 0.1 mol·L−1 NaOH solution, and an 
aliquot of the cell lysate was used to measure the 
cell-associated glucose.  Glucose uptake was estimated by 
using Biovision glucose estimation kit (Biovision Kit Inc, 
USA). Three independent experimental values, in duplicates 
were taken to determine the percentage enhancement of 
glucose uptake compared with control [11-12]. 
Reverse transcriptase-polymerase chain reaction (RT-PCR) 
RT-PCR was performed as published [11]. In short, after 
the completion of incubation, the cells were lysed in TRI 
Reagent, the protein content was extracted with chloroform, 
and the total RNA was precipitated with isopropanol. The 
RNA precipitate was washed with 70% ethanol, and resus-
pended in DEPC-treated water (50 µL).  Reverse transcrip-
tion was performed using 200 units of avian reverse transcrip-
tase, and 200 ng·μL−1 oligo d(T)18. The primers used were as 
follows, GLUT-4: sense, 5'-CGG GAC GTG GAG CTG GCC 
GAG GAG-3'; anti-sense, 5'CCC CCT CAG CGA GTG A-3' 
(318-bp) [12]; PPARγ; sense, 5'-GGA TTC ATG ACC AGG 
GAG TTC CTC-3'; anti-sense, 5'-GCG GTC TCC ACT GAG 
AAT AAT GAC-3’ (155-bp) [12]; glyceraldehydes-3-phosphate 
dehydrogenase (GAPDH); sense, 5'CCA CCC ATG GCA AAT 
TCC ATG GCA-3'; anti-sense, 5'-TCT AGA CGG CAG GTC 
AGG TCC ACC – 3' (588-bp) [12]. For PCR reaction, cDNA 
mixture (1 µL) was added to a PCR reaction mix containing 
10 × PCR buffer, 2 mmol·L−1 dNTP, 10 pmol·L−1 of paired 
primers, and 2 units of Taq polymerase. PCR products were 
run on 1.5% agarose gels, stained with ethidium bromide, and 
the gel was photographed by scanning densitometer. 
Statistical analysis 
All the values were expressed as x ± SEM. The results 
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were analyzed statistically using one way ANOVA followed by 
Tukey’s multiple comparison test using Graph Pad Prism version 
4.03 for Windows, Graph Pad Software, San Diego CA, USA. 
The minimum level of significance was fixed at P < 0.05. 
Results 
Extraction of the plant material 
The fruits powder of M. cymbalaria was successively ex-
tracted with hexane, dichloromethane, ethyl acetate, and 
methanol. The extractive values of hexane, dichloromethane, 
ethyl acetate, and methanol were found to be 0.6%, 0.45%, 
2.3%, and 3.2% W/W, respectively.   
Evaluation of glucose uptake  
The glucose uptake activity of MFMC was evaluated using 
a 50 μg·mL−1 concentration of rosiglitazone as reference stan-
dard, based on a pilot study (unpublished data). The MFMC at 
concentrations ranging from 62.5 to 500 μg·mL−1 showed 
dose-dependent stimulation of glucose uptake, at 500 μg·mL−1 
concentration it offered approximately two-fold increase in 
glucose uptake from the basal concentration of glucose, simi-
larly rosiglitazone also showed a significant increase in glu-
cose uptake. The results are given in Fig. 1. 
 
Fig. 1  Glucose uptake activity of methanolic extract of Momordica cymbalaria (MFMC) in L6 myotubes (x ± SEM, n = 3) 
Means of various groups were statistically compared by one way ANOVA followed by Tukey’s multiple comparison test using 
Graph Pad version 4.03. †P < 0.001 corresponds to rosiglitazone vs control; *P < 0.05, **P < 0.01, ***P < 0.001 vs MFMC vs control 
 
Further, the effect of MFMC on glucose uptake was 
thought to be mediating through enhanced expression of 
GLUT-4, and PPARγ synthesis, and thereby enhanced protein 
synthesis. To confirm this hypothesis, another set of experi-
ment was performed where the glucose uptake activity of 
MEMC was carried out in the presence of a protein synthesis 
inhibitor cycloheximide (CHX) in L6 myotubes, along with 
the previously included experimental groups. Remarkably, the 
glucose uptake activity of MFMC was abolished in the pres-
ence of CHX, which suggests that the enhanced glucose up-
take activity of MFMC, is mediating through enhanced pro-
tein synthesis (Fig. 4). 
Effect of MFMC on GLUT-4 and PPARγ transcription levels 
The effect of MFMC on GLUT-4, and PPARγ mRNA 
expression was determined by semi-quantitative RT-PCR.  
The MFMC and rosiglitazone elevated the transcription of 
GLUT-4 in L6 myotubes during 24 h of incubation, when 
compared to control. The scanning densitometric analysis of 
the agarose gel showed approximately a 2.1-fold increase in 
GLUT-4 transcription levels in the MFMC (500 μg·mL−1) 
treated group, when compared to control. The results are de-
picted in Figs. 2A, 2B, and 2C. 
Additionally, the role of PPARγ expression in glucose 
transport mediated by MFMC was investigated. Surprisingly, 
the MFMC treatment showed approximately a 2.5-fold in-
creased expression of PPARγ, when compared to control. 
These findings were in agreement with the findings of the in 
vitro glucose uptake assay.  Further, the L6 myotubes were 
analyzed for the GAPDH transcripts at 24 h (588bp). The 
representative signals of PPARγ in the agarose gel were 
quantified arbitrarily in three independent experiments, and 
representative agarose gels are shown Figs. 3A, 3B, and 3C. 
All these findings were in agreement with the conclusion 
that the enhanced glucose uptake activity of MFMC is medi-
ating through enhanced gene expression of GLUT-4 and 
PPAR-γ. Furthermore, the enhanced protein synthesis is the 
key factor in enhancing the glucose uptake, which was con-
firmed when the glucose uptake was completely abolished in 
presence of cycloheximide (CHD), which is a protein synthe-
sis inhibitor (Fig. 4).   
Discussion 
The abnormal glucose transport associated with deficient 
GLUT-4 translocation, and/or faulty insulin signaling cascade 
are manifested as among the dominant defects in insulin re-
sistance in type 2 diabetes. The intense rise in GLUT-4 and 
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Fig. 2  Effect of the methanolic fruit extract of Momordica  
cymbalaria (MFMC) on Glut-4 transcripts in L6 myotubes 
(x ± SEM, n = 3) 
M: Ikbp marker Lane 1: Indicates 500 µg·mL−1 MFMC, Lane 
2: indicates 250 µg·mL−1 MFMC, Lane 3: 125 µg MFMC, 
Lane 4: Rosiglitazone, Lane 5: control 
Means of various groups were statistically compared by one 
way ANOVA followed by Tukey’s multiple comparison test 
using Graph Pad version 4.03. *P < 0.05, **P < 0.01 vs control 
 
Fig. 3  Effect of methanolic fruit extract of Momordica  
cymbalaria (MFMC) on PPARγ transcripts in L6 myotubes  
(x ± SEM, n = 3) 
M: Ikbp marker Lane 1: indicates 500 µg·mL−1 MFMC, Lane 
2: indicates 250 µg·mL−1 MFMC, Lane 3: 125 µg MFMC, 
Lane 4: Rosiglitazone, Lane 5: control 
Means of various groups were statistically compared by one way 
ANOVA followed by Tukey’s multiple comparison test using 
Graph Pad version 4.03. *P < 0.05, **P < 0.01 vs control 
 
P13 kinase, mRNA levels in euglycemic and hyperinsu-
linemic clamp in the presence of insulin refined the role of 
GLUT-4, and P13 kinase in insulin-mediated glucose 
 
Fig. 4  Effect of cycloheximide on methanolic fruit extract of Momordica cymbalaria (MFMC) intervening glucose uptake.  
Note : ns, Not significant (x ± SEM, n = 3) 
Means of various groups were statistically compared by one way ANOVA followed by Tukey’s multiple comparison test using Graph Pad 
version 4.03. †P < 0.001 corresponds to Rosiglitazone vs control; *P < 0.05, **P < 0.01, ***P < 0.001 corresponds to MFMC vs control. nsP  > 
0.05 corresponds to MFMC + CHX vs MFMC 62.5 µg·mL−1 
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transport [13]. Apart from insulin, PPARγ agonists like 
rosiglitazone and pioglitazone have been shown to facili-
tate glucose transport in type 2 diabetes by acting as insu-
lin sensitizers [14]. Hence the up-regulation of such mo-
lecular switches reinforced their role in glucose transport. 
In the present study, an attempt was made to identify the 
mechanism behind the glucose uptake activity of MFMC 
in in vitro using L6 myotubes.   
In this context, the L6 muscle cell line was a suitable in 
vitro model to study glucose transport activity. Moreover, 
skeletal muscle is the major site for primary glucose clearance 
and glucose utilization [15]. Earlier reports of L6 myotubes 
evidenced the maximum glucose uptake in the presence of 
troglitazone and rosiglitazone at 10 and 100 µmol·L−1 con-
centrations, respectively [8]. In addition, the enhanced glucose 
uptake in L6 cells is mostly mediated through elevated 
GLUT-4 levels [8, 15]. In similar terms, the findings in the pre-
sent study are in agreement with the literature reports where 
there is a concomitant increase in glucose uptake along with 
the enhanced GLUT-4 levels in L6 myotubes, the MFMC has 
shown enhanced glucose uptake, and assisted the enhanced 
GLUT-4 expression. Furthermore, cycloheximide, a protein 
synthesis inhibitor, has completely blocked troglitazone-me-
diated glucose uptake on chronic exposure, suggesting the 
importance of new protein synthesis for glucose transport [8]. 
Similarly, in the present study the glucose uptake activity of 
MFMC was completely abolished by cycloheximide, which 
clearly confirmed the role of new protein synthesis relevant to 
glucose transport.   
Together, the above considerations established that glu-
cose uptake is dependent on increased or decreased expres-
sion of GLUT-4; Moreover, the enhanced glucose uptake in 
the present study was concomitant with the increased expres-
sion of GLUT-4 encoding mRNA in L6 myotubes upon incu-
bation with MFMC [16]. 
Additionally, the expression of PPARγ was also increased, 
together with increased expression of GLUT-4, and enhanced 
glucose uptake in L6 myotubes when incubated with MFMC. 
In support of these findings, PPARγ agonists are known to 
increase the GLUT-4 transcription by acting through PPARγ 
receptors [17]. 
Interestingly, the findings of the present study have con-
vincing inference to understand the mechanism governing  
the activation of glucose transport associated with MFMC.  
All the findings in the present study are in agreement to sup-
port the glucose uptake enhancing property of MFMC. Based 
on the gene expression study outcomes it was hypothesized 
that methanolic fruit extracts of M. cymbalaria could activate 
the glucose transport by up-regulation of GLUT-4 and PPARγ 
by acting as PPARγ agonist. Duplication of the above study in 
3T3 L1 adipocyte cell-line could help to better understand the 
mechanism of action of M. cymbalaria. 
Conclusion 
In the current study, the unifying approach of medicinal 
chemistry and in vitro screenings assays was manifested, 
which assured the evidence of a set of targets on glucose 
transport. Also this study demonstrated the importance of 
GLUT-4, and PPARγ up-regulation by the methanolic fruit 
extract of M. cymbalaria in enhancing glucose transport. Its 
role in augmenting glucose uptake by modulating a battery of 
targets like GLUT-4, PPARγ and their significance in such 
processes has been studied. Purification of the above plant 
extract towards the isolation of the active principle(s) is in 
progress. 
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